EX-FILING FEES 4 tm2220905d6_ex-filingfees.htm EX-FILING FEES


Exhibit 107


Calculation of Filing Fee Tables


Schedule TO
(Form Type)


Theravance Biopharma, Inc.
(Exact Name of Registrant as Specified in its Charter)


Table 1: Transaction Valuation


   Fee rate   Amount of
Filing Fee
Fees to Be Paid  $230,000,000*   0.00927%  $21,321**
Fees Previously Paid   -        $0 
Total Transaction Valuation  $230,000,000*          
Total Fees Due for Filing            $21,321 
Total Fees Previously Paid            $- 
Total Fee Offsets            $- 
Net Fee Due            $21,321 


* Calculated solely for purposes of determining the amount of the filing fee. The transaction valuation assumes that all $230,000,000 aggregate principal amount of the issuer’s 3.25% Convertible Senior Notes due 2023 are purchased at the tender offer price of $1,000 per $1,000 principal amount of such Convertible Notes.
** The amount of the filing fee was calculated in accordance with Rule 0-11 of the Securities Exchange Act of 1934, as amended, and equals $92.70 for each $1,000,000 of the value of the transaction.